˜Theœ kidney in plasma cell dyscrasias the first comprehensive discussion of diagnosis, pathogenesis and treatment

In recent years, the knowledge of how renal damage occurs in patients with plasma cell dyscrasias / myeloma has substantially increased. For the first time, this publication brings together issues relating to the diagnosis and pathogenesis of these disorders, as well as a summary of advances achieve...

Full description

Bibliographic Details
Main Author: Herrera, Guillermo A. ([Sonstige])
Format: eBook
Language:English
Published: Basel Karger 2007, 2007
Series:Contributions to nephrology
Subjects:
Online Access:
Collection: Karger eBooks Collection 1997-2013 - Collection details see MPG.ReNa
LEADER 02272nmm a2200289 u 4500
001 EB000289169
003 EBX01000000000000000085448
005 00000000000000.0
007 cr|||||||||||||||||||||
008 101101 ||| eng
020 |a 9783805581783 
100 1 |a Herrera, Guillermo A.  |e [Sonstige] 
245 0 0 |a ˜Theœ kidney in plasma cell dyscrasias  |h Elektronische Ressource  |b the first comprehensive discussion of diagnosis, pathogenesis and treatment  |c vol. ed.: Guillermo A. Herrera 
260 |a Basel  |b Karger  |c 2007, 2007 
653 |a Hematology 
653 |a Nephrology 
653 |a (DE-588)4075399-2 / Nierenkrankheit / gnd 
653 |a (DE-588)4280813-3 / Paraproteinämie / gnd 
653 |a Biochemistry 
653 |a Pathology 
041 0 7 |a eng  |2 ISO 639-2 
989 |b ZDB-1-KEB  |a Karger eBooks Collection 1997-2013 
490 0 |a Contributions to nephrology 
776 |z 9783318013979 
856 4 0 |u https://www.karger.com/Book/Home/232104  |x Verlag  |3 Volltext 
082 0 |a 610 
520 |a In recent years, the knowledge of how renal damage occurs in patients with plasma cell dyscrasias / myeloma has substantially increased. For the first time, this publication brings together issues relating to the diagnosis and pathogenesis of these disorders, as well as a summary of advances achieved in the treatment and management of patients. Several chapters are devoted to various glomerulopathies associated with deposition of immunoglobulin light and heavy chains, including those associated with amyloidosis. The sequential events are pointed out, crucial steps and key molecules open to modulation or control are delineated, and therapeutic advances are highlighted. Although the emphasis is on the management of cases with renal involvement, a distinct focus on the diseases as a whole and their impact on patients’ general health and prognosis has been maintained throughout the discussions.Using a translational approach to renal manifestations in patients with plasma cell dyscrasias / myelomas, this publication conveys a comprehensive state-of-the-art view of the subject. It is aimed at practicing renal pathologists, nephrologists, internists and hematologists, as well as at trainees and scientists working in these specialties